This announcement is a separate document:
赛伦生物：关于收到实际控制人之一、董事长2024年度中期分红提议暨落实“提质增效重回报”行动方案的公告
Shanghai Serum Bio-Technology: Announcement regarding the proposal for interim dividends in 2024 by one of the actual controlling shareholders and chairman, and the implementation of the "improving quality and efficiency, and returning value" action plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated